New Wave Holdings (SPOR.C) entered a joint venture with the University of West Indies for drug discovery and improve knowledge of medicinal plants in Jamaica, according to a press…
Pharmaceuticals
The collaboration will “accelerate the development of psilocybin in the treatment of cancer and the discovery of novel uses of undisclosed psychedelic compounds”….
A few states in our neighbour to the south decided to offer psilocybin based therapies during the most recent spate of elections, prompting more potential for companies like Xphyto…
Sick democracy – sick people – big profits. That was a cogitative jump that most investors seemed to make….
Today’s federal election results could change the regulatory landscape in Oregon and Washington DC, as the residents of those states will vote to decide if psilocybin should be decriminalised….
Mind Medicine (MMED.E) closed a bought deal short-form prospectus offering, issuing 27,381,500 units for $1.05 and brought in $28,750,575 today, according to a press release. After the financing, the…
Currently in Canada, the dry eye market is estimated at over $9O million, which includes both prescription and over-the-counter products….
Better Plant Sciences (PLNT.C) received a natural health product (NHP) number from Health Canada for their anti-microbial skin ointment product today, according to a press release. The company, a…
Earlier this year, when Revive Therapeutics (RVV.C) announced they had some pharma IP that may be relevant to the treatment of COVID-19, plenty of folks laughed uproariously at the…
It would seem the race to find a suitable treatment for COVID-19 is over, as Gilead Sciences (GILD.Q) announced today that their antiviral drug Veklury (remdesivir) received the nod…